Our Team
Meet the people behind our mission. Innovators working to advance new treatments for rare childhood cancers.
Co-Founder
Chief Scientific Officer
Tony is a PhD in organic chemistry by trade and a former Distinguished Research Fellow from Abbvie who joins the cc-TDI team, having been inspired by those he has known in their battle with cancer and the people striving to find treatments. Tony brings 31 years of pharmaceutical experience with an emphasis on clinical candidate development.
Co-Founder
Operational Leader
Cody, a 26-year Air Force veteran, lost his daughter to hepatoblastoma. Driven by her memory, he now leverages his global network and operational background to lead a foundation supporting rare disease research. A dedicated patient advocate, Cody connects disparate medical efforts to honor his daughter’s legacy alongside his supportive family.
Co-Founder
Charles is a Scientific Director & Founder, Children’s Cancer Therapy Development Institute (cc-TDI). Charles’ research focuses on developing more effective, less toxic therapies for childhood cancers, particularly advanced or unresectable disease. He has co-chaired the CNS-DVL committee and serves on the STS committee within the Children’s Oncology Group, and has also contributed as a member of NIH/NCI Study Sections.